Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes

José Carlos dos Santos; Barbro Beijer; Ulrike Bauder-Wüst; Martin Schäfer; Karin Leotta; Matthias Eder; Martina Benešová; Christian Kleist; Frederik Giesel; Clemens Kratochwil; Klaus Kopka; Uwe Haberkorn; Walter Mier

doi:10.2967/jnumed.119.229054

Research ArticleTheranostics

Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes

José Carlos dos Santos, Barbro Beijer, Ulrike Bauder-Wüst, Martin Schäfer, Karin Leotta, Matthias Eder, Martina Benešová, Christian Kleist, Frederik Giesel, Clemens Kratochwil, Klaus Kopka, Uwe Haberkorn and Walter Mier

Journal of Nuclear Medicine January 2020, 61 (1) 70-79; DOI: https://doi.org/10.2967/jnumed.119.229054

José Carlos dos Santos

1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Barbro Beijer

1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ulrike Bauder-Wüst

2Division of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Schäfer

2Division of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Karin Leotta

1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Eder

3Division of Radiopharmaceutical Development, German Cancer Consortium Freiburg, Department of Nuclear Medicine, University of Freiburg, Freiburg, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martina Benešová

2Division of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christian Kleist

1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frederik Giesel

1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Clemens Kratochwil

1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Klaus Kopka

2Division of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Uwe Haberkorn

1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

4Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Walter Mier

1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 61, Issue 1

January 1, 2020

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes

Journal of Nuclear Medicine Jan 2020, 61 (1) 70-79; DOI: 10.2967/jnumed.119.229054

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes

Journal of Nuclear Medicine Jan 2020, 61 (1) 70-79; DOI: 10.2967/jnumed.119.229054

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

61Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging

Google Scholar

Theranostics

¹⁷⁷Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Terbium-161, a Promising New Theranostic Radionuclide
Association of change in PSMA avid tumor burden during 177Lu-PSMA-617 therapy with overall survival: Should mid-point PET become standard protocol?

Show more Theranostics

Basic

Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression

Show more Basic

Keywords

PSMA
copper radioisotopes
radiotracer
prostate cancer
PET imaging
endoradiotherapy

Main menu

User menu

Search

Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Basic

Similar Articles

Keywords